TheEdgeResearch
Home / Stocks / IBRN

iShares Neuroscience and Healthcare ETF (IBRN)

AMEX Financial Services Asset Management
$39.57 ▲ +0.81%
Market Cap
$6.3M
Sector
Financial Services
Industry
Asset Management
Beta
0.87
52-Wk Range
24.01-40.42
CEO
Country
US
Currency
USD

iShares Neuroscience and Healthcare ETF operates in the Asset Management industry of the Financial Services sector, headquartered in San Francisco, CA, US. The stock last traded at $39.57, up 0.81% on the session, giving a market capitalisation of $6.3M. Its beta of 0.87 implies it has historically moved less than the broad market.

Company profile
Exchange
New York Stock Exchange Arca
Employees
IPO date
2022-08-24
Headquarters
San Francisco, CA, US
About iShares Neuroscience and Healthcare ETF

The iShares Neuroscience and Healthcare ETF (IBRN) aims to mirror the financial performance of a particular index. This index consists of companies, both domestically in the U.S. and from other countries, that are expected to benefit from new discoveries and the overall growth in the field of neuroscience.

Comparable companies

iShares Neuroscience and Healthcare ETF is most often compared with the following Financial Services names:

DYLGEPMBEPSVETECFOWFITDJSOLRTMDVUSNGXVOL
More research on IBRN
IBRN technical analysis IBRN TheEdge Score Compare against peers
Open full interactive analysis & DCF →